CRISPR Therapeutics (CRSP) Options Chain & Prices $52.35 -1.65 (-3.06%) Closing price 04:00 PM EasternExtended Trading$52.74 +0.39 (+0.75%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Options Chain Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest CRSP Put and Call Options List 1/19/2029 1/21/2028 4/16/2027 1/15/2027 11/20/2026 11/13/2026 11/6/2026 10/30/2026 10/23/2026 10/16/2026 10/9/2026 Options Date Put and Call Options Put Options Call Options Options Type All In The Money Out of The Money Moneyness With Volume Without Volume All Volume Strike Price Min Strike Price Max More filters Fewer filters Done 0 Results Export ExpiresStrike PriceClose PricePut/CallVolumeVolume AskVolume BidOpen InterestImplied VolatilityDeltaTrades10/9/2026$42.00$10.429Call2 - - 2(+2)127.85% (+25.41%)0.991808210/9/2026$43.00$9.434Call1 - - 1(+1)120.24% (+22.67%)0.988504110/9/2026$45.00$0.037Put30 - - 30(+0)105.53% (+17.21%)-0.024223210/9/2026$45.00$7.453Call8 - - 3(+2)105.53% (+17.21%)0.976518810/9/2026$46.00$6.469Call8 - - 2(+1)98.48% (+14.49%)0.965598810/9/2026$48.00$0.120Put1 - 122(+0)85.33% (+9.21%)-0.079276110/9/2026$49.00$0.190Put71676(+10)79.54% (+6.81%)-0.122876510/9/2026$50.00$0.313Put4 - 465(+6)74.70% (+4.83%)-0.192193110/9/2026$50.00$2.731Call1 - 135(+7)74.70% (+4.83%)0.809114110/9/2026$51.00$0.530Put94355(+5)71.35% (+3.65%)-0.2961295 Get the Latest News and Ratings for CRSP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for CRISPR Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 10/9/2026$52.00$0.893Put513210(+92)70.06% (+3.70%)-0.432075310/9/2026$52.00$1.308Call191186(+0)70.06% (+3.70%)0.571605410/9/2026$53.00$1.434Put109153(+24)71.05% (+5.07%)-0.576735410/9/2026$53.00$0.846Call211832(+1)71.05% (+5.07%)0.428877810/9/2026$54.00$2.136Put99 - 83(+64)73.90% (+7.33%)-0.701429210/9/2026$54.00$0.543Call1210276(+14)73.90% (+8.85%)0.305766310/9/2026$55.00$2.954Put61 - 31333(+70)77.92% (+9.94%)-0.794128510/9/2026$55.00$0.355Call19162272(+129)77.92% (+9.94%)0.21381910/9/2026$56.00$0.239Call82581(+16)82.54% (+12.53%)0.149806410/9/2026$57.00$0.166Call261311116(+11)87.41% (+14.95%)0.10628710/9/2026$58.00$0.118Call22 - 21214(+45)92.37% (+17.17%)0.076636910/9/2026$59.00$0.086Call2 - 2173(+25)97.29% (+19.23%)0.056204210/9/2026$60.00$0.064Call18710376(+45)102.14% (+21.14%)0.041898910/9/2026$62.00$0.037Call1 - 1105(+22)111.50% (+24.59%)0.0243341End-of-day options data provided by Trade Alert and Intrinio. Related Companies and Tools Related Companies Allogene Therapeutics Options Data Axsome Therapeutics Options Data Beam Therapeutics Options Data Editas Medicine Options Data Moderna Options Data Intellia Therapeutics Options Data Vertex Pharmaceuticals Options Data Exelixis Options Data Ascendis Pharma A/S Options Data Summit Therapeutics Options Data Options Chain Tools Short Interest TrackerShort Interest IncreasesShort Interest DecreasesUnusual Call VolumeUnusual Put Volume This page (NASDAQ:CRSP) was last updated on 10/7/2026 by MarketBeat.com Staff. From Our PartnersALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredTrump's New DollarPorter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. doll...Porter & Company | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredThe end may be near for these iconic stocksMarc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are ...Chaikin Analytics | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredHere’s Why Trump Won’t End The Iran WarTrump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CRISPR Therapeutics AG Please log in to your account or sign up in order to add this asset to your watchlist. Share CRISPR Therapeutics With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
